Quantification of CXCR5+BATF+IL-4+ cells revealed that approximately 60% of CXCR5+IL-4+ cells in an IgG4-RD patient with TLOs expressed BATF (Fig 2F). This evidence concerns the gene IL4 and immunoglobulin G4-related sclerosing disease.